Pitcairn’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $853K | Sell |
12,363
-2,102
| -15% | -$145K | 0.06% | 291 |
|
|
2025
Q1 | $1M | Sell |
14,465
-445
| -3% | -$30.9K | 0.06% | 271 |
|
|
2024
Q4 | $1.28M | Buy |
14,910
+527
| +4% | +$45.3K | 0.08% | 223 |
|
|
2024
Q3 | $1.71M | Sell |
14,383
-1,009
| -7% | -$120K | 0.1% | 184 |
|
|
2024
Q2 | $2.2M | Buy |
15,392
+476
| +3% | +$67.9K | 0.13% | 142 |
|
|
2024
Q1 | $1.92M | Buy |
14,916
+816
| +6% | +$105K | 0.12% | 162 |
|
|
2023
Q4 | $1.46M | Buy |
14,100
+5,676
| +67% | +$587K | 0.11% | 175 |
|
|
2023
Q3 | $766K | Buy |
8,424
+1,232
| +17% | +$112K | 0.06% | 260 |
|
|
2023
Q2 | $582K | Sell |
7,192
-134
| -2% | -$10.8K | 0.05% | 311 |
|
|
2023
Q1 | $583K | Buy |
7,326
+1,538
| +27% | +$122K | 0.05% | 307 |
|
|
2022
Q4 | $392K | Buy |
5,788
+120
| +2% | +$8.12K | 0.04% | 380 |
|
|
2022
Q3 | $282K | Buy |
5,668
+1,308
| +30% | +$65.1K | 0.03% | 451 |
|
|
2022
Q2 | $243K | Buy |
+4,360
| New | +$243K | 0.03% | 502 |
|
|
2016
Q1 | – | Sell |
-12,194
| Closed | -$354K | – | 487 |
|
|
2015
Q4 | $354K | Buy |
+12,194
| New | +$354K | 0.04% | 299 |
|
|
2015
Q3 | – | Sell |
-17,076
| Closed | -$468K | – | 450 |
|
|
2015
Q2 | $468K | Sell |
17,076
-430
| -2% | -$11.8K | 0.05% | 267 |
|
|
2015
Q1 | $467K | Buy |
17,506
+518
| +3% | +$13.8K | 0.05% | 272 |
|
|
2014
Q4 | $359K | Buy |
16,988
+514
| +3% | +$10.9K | 0.04% | 329 |
|
|
2014
Q3 | $392K | Buy |
16,474
+3,910
| +31% | +$93K | 0.04% | 310 |
|
|
2014
Q2 | $290K | Buy |
12,564
+786
| +7% | +$18.1K | 0.03% | 373 |
|
|
2014
Q1 | $269K | Buy |
+11,778
| New | +$269K | 0.03% | 390 |
|